Nanobiosensors for cardiac biomarker monitoring using electrochemical and optical detection
Cardiovascular disease remains a leading cause of morbidity and mortality worldwide, with acute coronary syndrome (ACS) accounting for a large portion of both the clinical and economic burden. Sensitive and specific cardiac biomarkers that enable rapid diagnosis of ACS and associated intervention can therefore profoundly impact accordingly. A diverse array of in vitro diagnostics exists for the detection of myriad cardiac biomarkers, notably troponin, CK-MB, and myoglobin, each capable of fulfilling diagnostic and/or prognostic roles. Recent advances in electrochemical and optical nanobiosensors have enabled highly sensitive, rapid, and point-of-care detection of cardiac biomarkers. The integration of nanomaterials, including gold nanoparticles, graphene derivatives, carbon nanotubes, and quantum dots, has significantly improved analytical performance by enhancing sensitivity, specificity, and signal amplification. This review systematically summarizes recent developments in nanobiosensor platforms for troponin, CK-MB, and myoglobin detection, highlighting sensing mechanisms, analytical performance, clinical applicability, current challenges, and future translational opportunities.
Authors
- Kumud Kant Awasthi (ORCID: https://orcid.org/0000-0001-8701-7574)
- Yash Bhardwaj (ORCID: https://orcid.org/0000-0002-8016-0420)
- Mahipal Singh Sankhla (ORCID: https://orcid.org/0000-0002-7361-3786)
- Vicky Kapoor
- Rishi Ranjan Kumar (ORCID: https://orcid.org/0000-0001-9859-5484)
- Garima Awasthi (ORCID: https://orcid.org/0000-0002-0038-1240)
- Anjali Awasthi (ORCID: https://orcid.org/0000-0001-7209-8666)
- Baljeet Yadav
Institutions
- KR Mangalam University (IN)
- University of Rajasthan (IN)
Publication Details
- Journal
- Discover Sensors
- Published
- 2026-11-18
- DOI
- https://doi.org/10.1007/s44397-026-00094-6
- Primary Topic
- Electrochemical sensors and biosensors
- Type
- article
- Field-Weighted Citation Impact
- 0.00